Prolonged sinus er atrial pause occurred in six patients with paroxysmal sup" ventricul-tachycardia after drug administra. tint,, All six patients had normal sinus node function during control electrophysiologic study; the sinus cycle length ranged from 310 to 900 ms (mean 743 ± 141) and the Ingest sinus node recovery time ranged from 800 to 1,230 mS (mean 1,018 ± 168) . A long sinus or atria) pause occurring at the teminatian of taehyeardla or cessation of atrial pacing, ranging from 3,100 to 8,200 ms (mean 6,270 ± 1,674), was provoked by the administration of various drags. These included an intravenous bolus injection of adenosine triphosphate (5 mg ; one patient), intravenous bolus injection of verapamil (5 mg ; one patient), a combination of a single oral dose of diltiazem 1120 mg) and propranolol (20 to 40 mg; three patients), oral diltiazem (240 mg/day ; one patient) and a combination of oral diltiazem (240 mg/day) and propranolol (160 mg/day; one patient) .
Prolonged sinus er atrial pause occurred in six patients with paroxysmal sup" ventricul-tachycardia after drug administra. tint,, All six patients had normal sinus node function during control electrophysiologic study; the sinus cycle length ranged from 310 to 900 ms (mean 743 ± 141) and the Ingest sinus node recovery time ranged from 800 to 1,230 mS (mean 1,018 ± 168) . A long sinus or atria) pause occurring at the teminatian of taehyeardla or cessation of atrial pacing, ranging from 3,100 to 8,200 ms (mean 6,270 ± 1,674), was provoked by the administration of various drags. These included an intravenous bolus injection of adenosine triphosphate (5 mg ; one patient), intravenous bolus injection of verapamil (5 mg ; one patient), a combination of a single oral dose of diltiazem 1120 mg) and propranolol (20 to 40 mg; three patients), oral diltiazem (240 mg/day ; one patient) and a combination of oral diltiazem (240 mg/day) and propranolol (160 mg/day; one patient) .
Termination of an acute episode of paroxysmal supraventricular tachycardia frequently requires parenteral drug administration, whereas prevention of recurrence of paroxysmal supraventricular tachycardia usually ,cgtdrca long-term oral drug administration (1 .2) . Although parentcral and long-term oral drug administration are safe, they may occasionally cause syncope as a result of prolonged sinus or atria) pauses (3-8), The mechanism of a drug-provoked long sinusoratrial pause is unclear . In this study, we investigated the mechanisms of drug-provoked sinus or atrial pauses using a sinus node electrogram recording in a group of patients with paroxysmal supraventricular tachycardia to whom a long sinus or atrial pause was provoked by drug administration. In five patients, low frequency deflections suggestive of sinus note activity with a cycle length between 620 and 3,500 ms were recorded during pauses. These findings suggest that repetitive sinoatrial exit block was responsible for the pause. Sinus slowing with a lung arrest suggesting suppression of sinus automaticity was also noted in three of these five patient'; the longest sinus arrest in these three patients was 4,160, 4,800 and >41,910 ms, respectively . The remaining patient with a pause of 6,840 rns had no recordable sinus activity, either reflecting suppression of sinus automaticity or technical failure .
In conclusion, this study suggests that both sinoatrial exit block and suppression of sinus automaticity are mechanisms for drug. provoked long sinus or atrial pauses, fJ Am Call Cardiol 1991 ;18x587-95)
Methods
Study patients . Criteria for inclusion of patients in this study were I) induction of sustained tachycardia in patients with clinically documented paroxysmal supraventricular tachycardia: 2) normal sinus nude function during control electrophysiolugic study; and 3) provocation of a prolonged sinus or ainal pause, defined as an interval >3 s after parcuteral or oral drug administration . From September 1986 to December 1989, a total of 121 consecutive patients with sustained paroxysmal supraventricular tachycardia were prospective)) studied. Six of the 121 patients developed a prolonged sinus or atrial pause after drug administration . There were five women and one man, aged 46 to 62 years (mean . 51) 56 . 6). None had demonstrable organic hear[ disease Electruphyslokigic study . The study protocol was approved by the Hospital Research Ethics Committee and written informed consent was obtained from all subjects. F.lecirnphysiologic study was performed with patients in a postabsorptive nonsedated state. All cardiac medication was discontinued x72 h (or 5 plasma half-lives) before study . Multiple electrode catheters were positioned in the high right atrium, coronary sinus, right ventricular apex and across the tricuspid valve for recording of intracardiac electrograms and pacing from different sites of the heart . Surface electroon5-109"wta2,5o Anlerograde and retrograde conduction properties were evaluated with atria) and ventricular incremental and extrastimulus testing techniques . The sinus node recovery time was evaluated otter sudden termination of overdrive atria) pacing tore, minimum of 30 s . It was measured as the interval from the last stimulus artifact to the first returning P wave that was consistent with sinus origin . The upper limit of normal for maximal sinus node recovery time was 1 .600 ms in our laboratory. Conduction intervals, refractory periods and echo zone were doused and measured as previously described R). Electrophysiulogic diagnosis of dual pathway atriovcntricutar (AV) node reentrant tachycnrdia and orthodromic AV reentrant Iachycardie was made using previously described criteria (2) . Drug therapy tar induced supraventrieular tachyeardia . Afterthe control study, sustained supraventricular lachycardin was induced, adenosine lriphosphate (5 to IS mg) was given intravenously as a bolus injection and the patient was monitored conuonously with recording of the sinus node elcctrograms. Ten to 20 min later, a second dose of adeno . sine triphosphate was administered to reconfirm the effects . After this, verapamil (5 to 10 mg) was administered intravenously during an induced episode of sustained supraventricular ruchycardia while the patient was monitored conlinunusly . This concluded the initial study . All electrode Catheters were removed ; a hexaputar electrode catheter was introduced through the right anlecubital vein, advanced to the right ventricular apex and secured for subsequent eice trophysiologic studies .
The followinr drugs were tested sequentially on separate days : a single oral dose of combined diltiazem (90 to 120 mg) and propranolol (20 to 80 mg) ; diltiazem (240 mg(day in four divided doses): verapamil (320 mg/day in four divided doses) ; quiaidine sulfate (1,600 mg/day in four divided doses) ; procainamide (4,000 mg/day in four divided doses) ; disopyramide phosphate (800 mg/day in four divided doses) ; propranolol (160 mg/day in four divided doses) ; a combination of diltiazem (240 mg/day in four divided doses) and propranelel 1160 mg/day in four divided doses) ; digoxin (1 .75 mg over a period of 24 h) ; and a combination of propranolol (160 mg/day in four divided doses) and digoxin (0.25 mg/day after a loading dose of 1 .75 mg) . When a prolonged atriat pause (re3 s) that occurred at termination of tachycardia or cessation of rapid atria) pacing was noted during the studies, a sinus node electrogram was recorded either by the four proximal electrodes (interelectrode distance of I cm) of the hexapolar electrode catheter (three patients) or by a newly introduced quadripolar electrode catheter if the hexapolar electrode catheter was unable to record a sinus node electrogram (three patients). Validation of sinus node electrugram . The sinus node elecirogram was validated by recording of multiple repetitive, identical, low frequency deflections free of beseli re drifting during an atria( pause that was noted on both the surface ECG and the high right atral electrogram (9) (10) (11) (12) (13) (14) . These low frequency deflections were recorded only at the critical area of rhejunclion of the superior vena cava and the right atrium . Moving the electrode catheter a few millimeters away from this area resulted in disappearance of these deflections . All measurements are presented as mean values SD,
Results
Clinical and ECG findings (Table 1) . Although all six patients had recurrent palpitation, none had syncope during palpitation or after spontaneous termination of palpitation . In one patient (Case 5) . two episodes of a prolonged atrial pause of 2.6 and 2 .8 s, respectively, were noted after termination of supraventricular tachycardia after a single oral dose of diltiazem (120 mgt and after an intravenous bolus injection of verapamil (4 mg) in the emergency room. The sinus cycle length at rest in these six patients ranged from 680 to (,000 ms (mean 853 Y 137). The QRS complexes were narrow in four of these six patients, intermittently pre-excited in one patient and persistently pre-excited in the Electraphysiolugic studies (Table 1) . During control study . the basic sinus cycle length ranged from 5101o 900 ms (mean 743 ± 141) . The sinoatrial conduction time ranged from 50 to 100 ms (mean 80 C 19) . The longest sinus node recovery time ranged from 800 to 1,230 ms (mean 1,019 t 1601 and corrected sinus node recovery time ranged from 140 to 3511 (mean 275 ± 86). Sustained supraventricular (achy cardia was inducible in all six patients, including five with orlhodromic AV reentrant tachycardia and one patient with slow-fast dual pathway AV node reentrant tachycardia . The Induced tachycardia had a cycle length ranging from 260 to 400 ms (mean 358 ± 5S) . No patient had a prolonged atria) page after electrical termination of tachycardia by overdrive pacing .
Drug provocation of prolonged atria( pause (Table 2 ) . All six patients had a prolonged atrial pause at termination of supraventncular tachycardia or cessation of rapid atria) pacing after drug administration . The drugs that provoked a long atral pause included adenosine triphusphate ( between 620 and 3,500 ms were observed in five patients (Patients I to 5 ; Fig. 2 to 5 ). Marked sinus slowing with a long arrest was also noted in three of these five patients ; the longest sinus arrest in the three patients was 4,160, 4,800 and >4,910 ms . respectively (Fig. 2B, 6A and 6B ). In the remaining patient (Patient 6), tow frequency deflections were not recorded after a long sinus pause of 6,840 ms when junctional escape rhythm with 1 :1 retrograde atrial conduction handicapped the recording of the sinus node clectrograms . In the six patients, the first returning beat after the atrial pause was of sinus origin in two patients (Patients I and 4; Fig . 2C and 5C ), junctional origin in two patients (Patients 2 and 6 ; Fig. 4B ) and atria) or junctional, or both, in the remaining two patients (Patients 3 and 5; Fig. 3B and 6B ) . Paroxysmal supraventricular tachycardia is a benign clinical arrhythmia. The acute attack is frequently terminated by a simple vagal maneuver or parenleral drug administration ; long-term prophylaxls is usually achieved by mainrrm nce oral drug administration (I). Patients with paroxysmal supraventricular tnchycardia may occasiortally experience sym cope at either the onset or the termination of an episode of tachyeardia . The former results from hyputensiun due to a sudden decrease in stroke volume (15) cr secondary to a vasovagal reflex triggered by tnchycardia-induced ealecholamlne secretion (16) . The latter results from a prolonged sinus or atria) pause at the termination of tachyeardia, especially in patients with sick sinus syndrome (17).
Autiarrhythmic agents and sinus node function . Betaadrenergic blockers . digitalis, calcium channel blockers, class I antiairhythmic drugs and adenosine are known to depress sinus node function, causing sinus bradycardia, prolongation of sinus node recovery time and lengthening of sinoatrial conduction time (18) (19) (20) (21) (22) . They are usually safe in clinical usage; symptomatic sinus node dysfunction occurs only rarely with acute parenteral administration or long-term oral administration of these agents . Nonetheless, cardiac adenosine in three patients with paroxysmal supravenlricutarIachycardia . Yen ct A . (7) observed severe sinus brady cardia with junctional escape rhythm in a patient after a single oral dose of a combination of dilliazem and propranclol was administered to terminate paroxysmal supravenlricular tachycardia . Koo el al . (8) reported on a 27 year old woman with automatic atria) lachycardia and no previous sinus node dysfunction who developed a sinus pause of8 .920 ms 5 days after treatment with digoxin (0 .25 mg)day), nadolol (80 mgdday) and amiodarone (I giday), A long sinus pause did not occur after discontinuation of drug therapy, but JACC Vol . Iv. Na . 2
August 1991 rcr95 rechallenge with amiodaruae caused prolonged cardiac asys • tole . Gould et al . (231 described a 77 year old woman who developed 2 :1 sinoatrial exit block while taking tocainide (400 mg three times daily) for premature ventricular beats . These previously reported episodes in patients with druginduced severe sinus depression usually occurred with preexisting sinus node dysfunction . The six patients in the present study had no clinical evidence of sinus node dysfunction or a history of syncope-In five of these six patients, the long sinus pause occurred after oral drug administration.
Mechanisms or drug-provoked prolonged sinus or aerial pause . Several studies (11) (12) (13) (14) have demonstrated that sinoatrial exit block rather than sinus node suppression is the major mechanism responsible for the abnormally prolonged sinus or atrial pause that occurs spontaneously after termination of supraventriculartachyarrhylhmia, after rapid atrial pacing or during carotid sinus massage . In these cases, Mobitz type 11 or type l exit block with repetitive sinoatrial exit block is the mechanism of the prolonged pause (11) (12) (13) • Complete sinoatrial exit block with atria) escape rhythm has also been shown (l4) to be present in some patients with the bradycardia-tachycardiasyndrome . Whether a similar mechanism is also responsible for the drug-provoked long sinus or atria] pause has not been clarified previously . The present study demonstrates that repetitive sinoalnal exit block is the major mechanism responsible for the drug-provoked long sinus or atria] pause in patients without evidence of previous sinus node dysfunction . However, it is usually accompanied by suppression of sinus automaticity with sinus arrest . Sinoatrial exit block was documented in five of the six patients with a recordable sinus node etect,ogram, whereas slowing of sinus automaticity with a long sinus arrest was noted in three of these five patients . In the remaining patient with no recordable scans node electrogram during a long p•s ase, inability to record the sinus node electrogram could reflect either suppression of sinus automaticity or technical failure . Clinical implications. This study has several clinical implications. Firs, both sinoatrial exit block and suppression of sinus automaticity are mechanisms of a drug-provoked long sinus or atria] pause in patients with paroxysmal supraventricular tachycardia without previous sick sinus syndrome, However, sinoatrial exit block appears to be the major mechanism. Second . a long sinus or atria) pause could he the mechanism of syncope in patients with paroxysmal supraventricular tachycardia when the combination of a beta-blacker and a calcium channel blacker is administered . Third, a long sinus or atria) pause could be a potential mechanism of syncope in patients with coronary artery disease when the patient is treated with the combination of a 
